CP-866087 - AN OVERVIEW

CP-866087 - An Overview

Watch Closely (one)siponimod and bortezomib both equally increase immunosuppressive outcomes; danger of infection. Use Caution/Watch. Caution if coadministered thanks to additive immunosuppressive consequences through this kind of therapy and during the weeks following administration.levoketoconazole will raise the stage or influence of bortezomib

read more